Cargando…

Targeted Screening for Chronic Q Fever, the Netherlands

Early detection of and treatment for chronic Q fever might prevent potentially life-threatening complications. We performed a chronic Q fever screening program in general practitioner practices in the Netherlands 10 years after a large Q fever outbreak. Thirteen general practitioner practices locate...

Descripción completa

Detalles Bibliográficos
Autores principales: Reukers, Daphne F.M., de Boer, Pieter T., Loohuis, Alfons O., Wever, Peter C., Bleeker-Rovers, Chantal P., van Gageldonk-Lafeber, Arianne B., van der Hoek, Wim, Timen, Aura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239892/
https://www.ncbi.nlm.nih.gov/pubmed/35731163
http://dx.doi.org/10.3201/eid2807.212273
_version_ 1784737412864278528
author Reukers, Daphne F.M.
de Boer, Pieter T.
Loohuis, Alfons O.
Wever, Peter C.
Bleeker-Rovers, Chantal P.
van Gageldonk-Lafeber, Arianne B.
van der Hoek, Wim
Timen, Aura
author_facet Reukers, Daphne F.M.
de Boer, Pieter T.
Loohuis, Alfons O.
Wever, Peter C.
Bleeker-Rovers, Chantal P.
van Gageldonk-Lafeber, Arianne B.
van der Hoek, Wim
Timen, Aura
author_sort Reukers, Daphne F.M.
collection PubMed
description Early detection of and treatment for chronic Q fever might prevent potentially life-threatening complications. We performed a chronic Q fever screening program in general practitioner practices in the Netherlands 10 years after a large Q fever outbreak. Thirteen general practitioner practices located in outbreak areas selected 3,419 patients who had specific underlying medical conditions, of whom 1,642 (48%) participated. Immunofluorescence assay of serum showed that 289 (18%) of 1,642 participants had a previous Coxiella burnetii infection (IgG II titer >1:64), and 9 patients were suspected of having chronic Q fever (IgG I y titer >1:512). After medical evaluation, 4 of those patients received a chronic Q fever diagnosis. The cost of screening was higher than estimated earlier, but the program was still cost-effective in certain high risk groups. Years after a large Q fever outbreak, targeted screening still detected patients with chronic Q fever and is estimated to be cost-effective.
format Online
Article
Text
id pubmed-9239892
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-92398922022-07-06 Targeted Screening for Chronic Q Fever, the Netherlands Reukers, Daphne F.M. de Boer, Pieter T. Loohuis, Alfons O. Wever, Peter C. Bleeker-Rovers, Chantal P. van Gageldonk-Lafeber, Arianne B. van der Hoek, Wim Timen, Aura Emerg Infect Dis Research Early detection of and treatment for chronic Q fever might prevent potentially life-threatening complications. We performed a chronic Q fever screening program in general practitioner practices in the Netherlands 10 years after a large Q fever outbreak. Thirteen general practitioner practices located in outbreak areas selected 3,419 patients who had specific underlying medical conditions, of whom 1,642 (48%) participated. Immunofluorescence assay of serum showed that 289 (18%) of 1,642 participants had a previous Coxiella burnetii infection (IgG II titer >1:64), and 9 patients were suspected of having chronic Q fever (IgG I y titer >1:512). After medical evaluation, 4 of those patients received a chronic Q fever diagnosis. The cost of screening was higher than estimated earlier, but the program was still cost-effective in certain high risk groups. Years after a large Q fever outbreak, targeted screening still detected patients with chronic Q fever and is estimated to be cost-effective. Centers for Disease Control and Prevention 2022-07 /pmc/articles/PMC9239892/ /pubmed/35731163 http://dx.doi.org/10.3201/eid2807.212273 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Reukers, Daphne F.M.
de Boer, Pieter T.
Loohuis, Alfons O.
Wever, Peter C.
Bleeker-Rovers, Chantal P.
van Gageldonk-Lafeber, Arianne B.
van der Hoek, Wim
Timen, Aura
Targeted Screening for Chronic Q Fever, the Netherlands
title Targeted Screening for Chronic Q Fever, the Netherlands
title_full Targeted Screening for Chronic Q Fever, the Netherlands
title_fullStr Targeted Screening for Chronic Q Fever, the Netherlands
title_full_unstemmed Targeted Screening for Chronic Q Fever, the Netherlands
title_short Targeted Screening for Chronic Q Fever, the Netherlands
title_sort targeted screening for chronic q fever, the netherlands
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239892/
https://www.ncbi.nlm.nih.gov/pubmed/35731163
http://dx.doi.org/10.3201/eid2807.212273
work_keys_str_mv AT reukersdaphnefm targetedscreeningforchronicqfeverthenetherlands
AT deboerpietert targetedscreeningforchronicqfeverthenetherlands
AT loohuisalfonso targetedscreeningforchronicqfeverthenetherlands
AT weverpeterc targetedscreeningforchronicqfeverthenetherlands
AT bleekerroverschantalp targetedscreeningforchronicqfeverthenetherlands
AT vangageldonklafeberarianneb targetedscreeningforchronicqfeverthenetherlands
AT vanderhoekwim targetedscreeningforchronicqfeverthenetherlands
AT timenaura targetedscreeningforchronicqfeverthenetherlands